Funding for this research was provided by:
Ethypharm SAS
Article History
Accepted: 9 October 2022
First Online: 4 November 2022
Declarations
:
: This study was funded by Ethypharm SAS.
: Nicolas Atrux-Tallau, Zulaikha Naimi, and Eric-Olivier Jaudinot are employed by Ethypharm SAS.
: All studies were conducted in accordance with the ethical principles of the Declaration of Helsinki, the ICH Guideline E6 for GCP, European regulation EU 536/2014, and the Tri-Council Policy Statement (Canada). The study protocols were approved by Health Canada and by an independent Institutional Review Board (Advarra).
: Informed consent was obtained from all participants included in this study.
: All data were anonymized and participants were informed that the results of this study may be subject to publication and presentation in meetings.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: Material preparation, data collection and analysis were performed by NAT, ZN and EOJ. The first draft of the manuscript was written by NAT and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.